PROSTATE CANCER Multiparametric MRI is better than a nomogram for predicting high-risk disease

被引:0
|
作者
Phillips, Robert
机构
关键词
D O I
10.1038/nrurol.2014.161
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:426 / 426
页数:1
相关论文
共 50 条
  • [1] Multiparametric MRI is better than a nomogram for predicting high-risk disease
    Robert Phillips
    Nature Reviews Urology, 2014, 11 : 426 - 426
  • [2] Development of a novel nomogram for predicting clinically significant prostate cancer with the prostate health index and multiparametric MRI
    Mo, Li-Cai
    Zhang, Xian-Jun
    Zheng, Hai-Hong
    Huang, Xiao-peng
    Zheng, Lin
    Zhou, Zhi-Rui
    Wang, Jia-Jia
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [3] Multiparametric MRI radiomics for predicting disease-free survival and high-risk histopathological features for tumor recurrence in endometrial cancer
    Renton, Mary
    Fakhriyehasl, Mina
    Weiss, Jessica
    Milosevic, Michael
    Laframboise, Stephane
    Rouzbahman, Marjan
    Han, Kathy
    Jhaveri, Kartik
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [4] Simultaneous whole-body PET/MRI with integrated multiparametric MRI for primary staging of high-risk prostate cancer
    Kaufmann, Sascha
    Kruck, Stephan
    Gatidis, Sergios
    Hepp, Tobias
    Thaiss, Wolfgang M.
    Hennenlotter, Joerg
    Schwenck, Johannes
    Scharpf, Marcus
    Nikolaou, Konstantin
    Stenzl, Arnulf
    Reischl, Gerald
    la Fougere, Christian
    Bedke, Jens
    WORLD JOURNAL OF UROLOGY, 2020, 38 (10) : 2513 - 2521
  • [5] Simultaneous whole-body PET/MRI with integrated multiparametric MRI for primary staging of high-risk prostate cancer
    Sascha Kaufmann
    Stephan Kruck
    Sergios Gatidis
    Tobias Hepp
    Wolfgang M. Thaiss
    Jörg Hennenlotter
    Johannes Schwenck
    Marcus Scharpf
    Konstantin Nikolaou
    Arnulf Stenzl
    Gerald Reischl
    Christian la Fougère
    Jens Bedke
    World Journal of Urology, 2020, 38 : 2513 - 2521
  • [6] A natural history study of men with high-risk genetics for prostate cancer (PCa) using multiparametric MRI (mpMRI).
    Karzai, Fatima
    Couvillon, Anna
    McKinney, Yolanda
    Lee-Wisdom, Katherine
    Choyke, Peter L.
    Giri, Veda N.
    Morgan, Todd M.
    Cheng, Heather H.
    Merino, Maria J.
    Pinto, Peter A.
    Turkbey, Baris
    Dahut, William L.
    CANCER RESEARCH, 2021, 81 (13)
  • [7] Nomogram Predicting Downgrading in National Comprehensive Cancer Network High-risk Prostate Cancer Patients Treated with Radical Prostatectomy
    Wenzel, Mike
    Wuernschimmel, Christoph
    Chierigo, Francesco
    Flammia, Rocco Simone
    Tian, Zhe
    Shariat, Shahrokh F.
    Gallucci, Michele
    Terrone, Carlo
    Saad, Fred
    Tilki, Derya
    Graefen, Markus
    Becker, Andreas
    Kluth, Luis A.
    Mandel, Philipp
    Chun, Felix K. H.
    Karakiewicz, Pierre I.
    EUROPEAN UROLOGY FOCUS, 2022, 8 (05): : 1133 - 1140
  • [8] 68Ga-PSMA-11 PET: Better at Detecting Prostate Cancer than Multiparametric MRI?
    Civelek, A. Cahid
    RADIOLOGY, 2018, 289 (03) : 738 - 739
  • [9] Unlocking the Benefits of Multiparametric MRI for Predicting Prostate Cancer Recurrence
    Aguirre, Diego A.
    Ortegon, Jose David Cardona
    RADIOLOGY, 2023, 309 (02)
  • [10] Inherited risk for prostate cancer (PCa): Following the natural history of men with high-risk genetics using multiparametric MRI (mpMRI).
    Couvillon, Anna
    Turkbey, Baris
    Choyke, Peter L.
    Lee-Wisdom, Katherine
    McKinney, Yolanda
    Sidlow, Robert
    Mullane, Michael P.
    Giri, Veda N.
    Morgan, Todd Matthew
    Cheng, Heather H.
    Merino, Maria J.
    Figg, William Douglas
    Pinto, Peter A.
    Dahut, William L.
    Karzai, Fatima
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41